Dynamics of Biofilm Formation and the Interaction between Candida albicans and Methicillin-Susceptible (MSSA) and -Resistant Staphylococcus aureus (MRSA)

JW Costerton, 1999, Bacterial biofilms: a common cause of persistent infections, Science, 284, 1318, 10.1126/science.284.5418.1318

J Chandra, 2001, Antifungal resistance of candidal biofilms formed on denture acrylic in vitro, J Dent Res, 80, 903, 10.1177/00220345010800031101

PV Sanitá, 2011, <italic>Candida</italic> spp. prevalence in well controlled type 2 diabetic patients with denture stomatitis, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 111, 726, 10.1016/j.tripleo.2011.02.033

S Abe, 2001, Prevalence of potential respiratory pathogens in the mouths of elderly patients and effects of professional oral care, Arch Gerontol Geriatr, 32, 45, 10.1016/S0167-4943(00)00091-1

MM Harriott, 2009, <italic>Candida albicans</italic> and <italic>Staphylococcus aureus</italic> form polymicrobial biofilms: effects on antimicrobial resistance, Antimicrob Agents Ch, 53, 3914, 10.1128/AAC.00657-09

AL Colombo, 1999, High rate of non-<italic>albicans</italic> candidemia in Brazilian tertiary care hospitals, Diagn Microbiol Infect Dis, 34, 281, 10.1016/S0732-8893(99)00042-5

AJ Smith, 2003, <italic>Staphylococcal</italic> species in the oral cavity from patients in a regional burns unit, J Hosp Infect, 55, 184, 10.1016/j.jhin.2003.08.004

HK Kuramitsu, 2007, Interspecies interactions within oral microbial communities, Microbiol Mol Biol Rev, 71, 653, 10.1128/MMBR.00024-07

ZM Thein, 2006, Effect of oral bacteria on growth and survival of <italic>Candida albicans</italic> biofilms, Arch Oral Biol, 51, 672, 10.1016/j.archoralbio.2006.02.005

T Baena-Morroy, 2004, <italic>Candida albicans</italic>, <italic>Staphylococcus aureus</italic> and <italic>Streptococcus mutans</italic> colonization in patients wearing dental prosthesis, Oral Medicine and Pathology, 10, 27

E Carlson, 1983, Effect of strain of <italic>Staphylococcus aureus</italic> on synergism with <italic>Candida albicans</italic> resulting in mouse mortality and morbidity, Infect Immun, 42, 285, 10.1128/IAI.42.1.285-292.1983

MM Harriott, 2010, Ability of <italic>Candida albicans</italic> mutants to induce <italic>Staphylococcus aureus</italic> vancomycin resistance during polymicrobial biofilm formation, Antimicrob. Agents Chemother, 54, 3746, 10.1128/AAC.00573-10

C Ibarra-Trujillo, 2012, Formation and quantification assay of <italic>Candida albicans</italic> and <italic>Staphylococcus aureus</italic> mixed biofilm, Rev Iberoam Micol, 29, 214, 10.1016/j.riam.2012.02.003

BM Peters, 2010, Microbial interactions and differential protein expression in <italic>Staphylococcus aureus-Candida albicans</italic> dual-species biofilms, FEMS Immunol Med Microbiol, 59, 493, 10.1111/j.1574-695X.2010.00710.x

E Carlson, 1985, Protection by <italic>Candida albicans</italic> of <italic>Staphylococcus aureus</italic> in the establishment of dual infection in mice, Infect Immun, 50, 655, 10.1128/IAI.50.3.655-659.1985

ME Shirtliff, 2009, Cross-kingdom interactions: <italic>Candida albicans</italic> and bacteria, FEMS Microbiol Lett, 299, 1, 10.1111/j.1574-6968.2009.01668.x

RG Faix, 1989, Polymicrobial sepsis among intensive care nursery infants, J. Perinatol, 9, 131

RA Calderone, 2001, Virulence factors of <italic>Candida albicans</italic>, Trends Microbiol, 9, 327, 10.1016/S0966-842X(01)02094-7

SA Klotz, 2007, Polymicrobial bloodstream infections involving <italic>Candida</italic> species: analysis of patients and review of the literature, Diagn Microbiol Infect Dis, 59, 401, 10.1016/j.diagmicrobio.2007.07.001

PR Chadwick, 1999, Revised UK guidelines for the control of methicillin-resistant <italic>Staphylococcus aureus</italic> in hospitals, Int J Antimicrob Agents, 11, 89

E Palavecino, 2004, Community-acquired methicillin-resistant <italic>Staphylococcus aureus</italic> infections, Clin Lab Med, 24, 403, 10.1016/j.cll.2004.03.007

RJ Gordon, 2008, Pathogenesis of Methicillin-Resistant <italic>Staphylococcus aureus</italic> Infection, Clinical Infectious Diseases, 46, 359, 10.1086/533591

BM Peters, 2012, <italic>Staphylococcus aureus</italic> adherence to <italic>Candida albicans</italic> hyphae is mediated by the hyphal adhesin Als3p, Microbiology, 158, 2975, 10.1099/mic.0.062109-0

1999, National Nosocomial Infections Surveillance System (NNIS) report, data summary from January 1990-May 1999, Am J Infect Control, 27, 520, 10.1016/S0196-6553(99)70031-3

J Mylotte, 2002, Nursing home-acquired pneumonia, Clin Infect Dis, 35, 1205, 10.1086/344281

MS Terpenning, 2001, Aspiration pneumonia: dental and oral risk factors in an older veteran population, J Am Geriatr Soc, 49, 557, 10.1046/j.1532-5415.2001.49113.x

PV Sanitá, 2014, In vitro evaluation of the enzymatic activity profile of non-<italic>albicans Candida</italic> species isolated from patients with oral candidiasis with or without diabetes, Oral Surg Oral Med Oral Pathol Oral Radiol, 118, 84, 10.1016/j.oooo.2014.03.020

PV Sanitá, 2014, Enzymatic activity profile of a Brazilian culture collection of <italic>Candida albicans</italic> isolated from diabetics and non-diabetics with oral candidiasis, Mycoses, 57, 351, 10.1111/myc.12162

LM Schlecht, 2015, Systemic <italic>Staphylococcus aureus</italic> infection mediated by <italic>Candida albicans</italic> hyphal invasion of mucosal tissue, Microbiology, 161, 168, 10.1099/mic.0.083485-0

X Hua, 2009, Morphogenic and genetic differences between <italic>Candida albicans</italic> strains are associated with keratomycosis virulence, Mol Vis, 15, 1476

DM O'Day, 2000, Differences in virulence between two <italic>Candida albicans</italic> strains in experimental keratitis, Invest Ophthalmol Vis Sci, 41, 1116

S Stepanovic, 2000, A modified microtiter-plate test for quantification of <italic>staphylococcal</italic> biofilm formation, J Microbiol Methods, 40, 175, 10.1016/S0167-7012(00)00122-6

KT Altieri, 2012, Effectiveness of two disinfectant solutions and microwave irradiation in disinfecting complete dentures contaminated with methicillin-resistant <italic>Staphylococcus aureus</italic>, JADA, 143, 270

CA Pereira, 2011, Susceptibility of <italic>Candida albicans</italic>, <italic>Staphylococcus aureus</italic>, and <italic>Streptococcus mutans</italic> biofilms to photodynamic inactivation: an in vitro study, Lasers Med Sci, 26, 341, 10.1007/s10103-010-0852-3

S Silva, 2010, In Vitro Biofilm Activity of Non-<italic>Candida albicans Candida</italic> Species, Curr Microbiol, 61, 534, 10.1007/s00284-010-9649-7

S Silva, 2009, Biofilms of non-<italic>Candida albicans Candida</italic> species: quantification, structure and matrix composition, Med Mycol, 47, 681, 10.3109/13693780802549594

S Roveta, 2008, Activity of daptomycin on biofilms produced on a plastic support by <italic>Staphylococcus</italic> spp, Int J Antimicrob Agents, 31, 321, 10.1016/j.ijantimicag.2007.11.012

K Smith, 2009, Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant <italic>Staphylococcus aureus</italic> biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin, Int J Antimicrob Agents, 33, 374, 10.1016/j.ijantimicag.2008.08.029

MA Al-Fattani, 2006, Biofilm matrix of <italic>Candida albicans</italic> and <italic>Candida tropicalis</italic>: chemical composition and role in drug resistance, J. Med Microbiol, 55, 999, 10.1099/jmm.0.46569-0

G Ramage, 2002, The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in <italic>Candida albicans</italic>, FEMS Microbiol Lett, 214, 95, 10.1111/j.1574-6968.2002.tb11330.x

CV Bamford, 2009, <italic>Streptococcus gordonii</italic> modulates <italic>Candida albicans</italic> biofilm formation through intergeneric communication, Infect Immun, 77, 3696, 10.1128/IAI.00438-09

BM Peters, 2013, <italic>Candida albicans-Staphylococcus aureus</italic> Polymicrobial Peritonitis Modulates Host Innate Immunity, Infection and Immunity, 81, 2178, 10.1128/IAI.00265-13

JP Lyon, 2006, Correlation between adhesion, enzyme production, and susceptibility to fluconazole in <italic>Candida albicans</italic> obtained from denture wearers, Oral Med Oral Pathol Oral Radiol Endod, 102, 632, 10.1016/j.tripleo.2005.12.015

R Rajendran, 2010, Hydrolytic enzyme production is associated with <italic>Candida albicans</italic> biofilm formation from patients with type I diabetes, Mycopathologia, 170, 229, 10.1007/s11046-010-9319-0

H Kaminishi, 1995, Degradation of humoral host defense by <italic>Candida albicans</italic> proteinase, Infect Immun, 63, 984, 10.1128/IAI.63.3.984-988.1995

MA El-Azizi, 2004, Interactions of <italic>Candida albicans</italic> with other <italic>Candida</italic> spp. and bacteria in the biofilms, J. Appl. Microbiol, 96, 1067, 10.1111/j.1365-2672.2004.02213.x

B Hube, 1996, <italic>Candida albicans</italic> secreted aspartyl proteases, Curr Top Med Mycol, 1, 55

JR Naglik, 1999, In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis, Infect Immun, 67, 2482, 10.1128/IAI.67.5.2482-2490.1999

A Salyers, 1994, Bacterial Pathogenesis: a Molecular Approach

MA Ghannoum, 2000, Potential role of phospholipases in virulence and fungal pathogenesis, Clin Microbiol Rev, 13, 122, 10.1128/CMR.13.1.122-143.2000

M Manfredi, 2006, In vitro evaluation of virulence attributes of <italic>Candida</italic> spp. isolated from patients affected by diabetes mellitus, Oral Microbiol Immunol, 21, 183, 10.1111/j.1399-302X.2006.00275.x

M Pande, 2006, A novel serine protease cryptolepain from <italic>Cryptolepis buchanani</italic>: purification and biochemical characterization, J Agric Food Chem, 54, 10141, 10.1021/jf062206a

L Taniguchi, 2009, Proposal of a low-cost protocol for colorimetric semi-quantification of secretory phospholipase by <italic>Candida albicans</italic> grown in planktonic and biofilm phases, J Microbiol Methods, 78, 171, 10.1016/j.mimet.2009.05.012

VL Bosco, 2003, Yeasts from the oral cavity of children with AIDS: exoenzyme production and anti-fungal resistance, Pesqui Odontol Bras, 17, 217, 10.1590/S1517-74912003000300004

A D’Eça Júnior, 2011, In vitro differential activity of phospholipases and acid proteinases of clinical isolates of <italic>Candida</italic>, Rev Soc Bras Med Trop, 44, 334, 10.1590/S0037-86822011005000036

M Negri, 2010, Examination of potential virulence factors of <italic>Candida tropicalis</italic> clinical isolates from hospitalized patients, Mycopathologia, 169, 175, 10.1007/s11046-009-9246-0

E Pinto, 2008, Correlation between enzyme production, germ tube formation and susceptibility to fluconazole in <italic>Candida</italic> species isolated from patients with denture-related stomatitis and control individuals, J Oral Pathol Med, 37, 587, 10.1111/j.1600-0714.2008.00687.x